| In ZINC since | Heavy atoms | Benign functionality |
|---|---|---|
| November 5th, 2008 | 30 | No |
nitrophenyl)-3,5-pyridinedicarboxylic acid 2-methoxyethyl-1-methylethyl Ester
1,4-Dihydro-2,6-dimethyl-4-(3&prime
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid
2-methoxyethyl propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
2-Methoxyethyl-1-methylethyl ester
3,5-pyridinecarboxylic acid 2-methoxyethyl 1-methylethyl ester
4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-N,N-dimethyl-2,2-diphenyl-butanamide
66085-59-4; C07267; Nimodipine
66085-59-4; D00438; Nimodipine (USAN/INN); Nimotop (TN)
CPD000058300; NIMODIPINE; SAM001246890
Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate
Isopropyl 2-methoxyethyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
ISOPROPYLMETHOXYETHYLDIMETHYLNITROPHENYLDIHYDROPYRIDINEDICARBOXYLAT
nimodipine; nimodipino; nimodipinum
Nimodipino [INN-Spanish];Nimodipinum [INN-Latin]
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | 4.10 | 11.26 | -18.9 | 1 | 9 | 0 | 120 | 418.446 | 10 | ↓ |
| Note Type | Comments | Provided By |
|---|---|---|
| ALOGPS_SOLUBILITY | 1.20e-02 g/l | DrugBank-approved |
| MP | 125 °C | Fluorochem |
| purity | 9.500000000000000e+001 | Enamine Building Blocks Enamine Building Blocks |
| Purity | >98% | Fluorochem |
| Indications | antihypertension | KeyOrganics Bioactives |
| Target | Autophagy,Calcium Channel | Selleck Chemicals |
| mechanism | Blocks intracellular influx of calcium that is thought to be a central to ischaemic neuronal damage. | IBScreen Bioactives |
| Purity | BP2000 | APIChem |
| mechanism | Calcium channel blockader | IBScreen Bioactives IBScreen Bioactives |
| biological_use | Cerebral vasodilator | IBScreen Bioactives |
| Indications | cerebral vasospasm and ischemia resulting from cerebral hemorrhage | KeyOrganics Bioactives |
| Warnings | IRRITANT | Matrix Scientific |
| PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : Sigma Chemical Company; NCC_SUPPLIER_STRUCTURE_ID : N149 | NIH Clinical Collection via PubChem |
| mechanism | Nimodipine binds specifically to L-type voltage-gated calcium channels | IBScreen Bioactives |
| Target | Others | Selleck Chemicals |
| Therapy | Potent L-type Ca2+ channel antagonist | SMDC Iconix |
| PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: Sigma Chemical Company; SUPPLIER_STRUCTURE_ID: N149 | NIH Clinical Collection via PubChem |
| therap | vasodilator | MicroSource Spectrum |
| Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| AA3R-1-E | Adenosine Receptor A3 (cluster #1 Of 6), Eukaryotic | Eukaryotes | 8470 | 0.24 | Binding ≤ 10μM |
| TRPA1-4-E | Transient Receptor Potential Cation Channel Subfamily A Member 1 (cluster #4 Of 6), Eukaryotic | Eukaryotes | 800 | 0.28 | Functional ≤ 10μM |
| Z50425-3-O | Plasmodium Falciparum (cluster #3 Of 22), Other | Other | 7943 | 0.24 | Functional ≤ 10μM |
| Z50512-1-O | Cavia Porcellus (cluster #1 Of 7), Other | Other | 15 | 0.37 | Functional ≤ 10μM |
| Z50597-1-O | Rattus Norvegicus (cluster #1 Of 1), Other | Other | 690 | 0.29 | ADME/T ≤ 10μM |
| Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| AA3R_HUMAN | P33765 | Adenosine A3 Receptor, Human | 8470 | 0.24 | Binding ≤ 10μM |
| Z50512 | Z50512 | Cavia Porcellus | 14.9 | 0.37 | Functional ≤ 10μM |
| Z50425 | Z50425 | Plasmodium Falciparum | 10000 | 0.23 | Functional ≤ 10μM |
| TRPA1_MOUSE | Q8BLA8 | Transient Receptor Potential Cation Channel Subfamily A Member 1, Mouse | 800 | 0.28 | Functional ≤ 10μM |
| Z50597 | Z50597 | Rattus Norvegicus | 690 | 0.29 | ADME/T ≤ 10μM |
| Description | Species |
|---|---|
| Adenosine P1 receptors | |
| G alpha (i) signalling events | |
| TRP channels |